http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014516918-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
filingDate | 2012-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2014-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2014516918-A |
titleOfInvention | Crystals of fused heterocyclic compounds |
abstract | The present invention relates to 1-ethyl-7-methyl-3- {4-[(3-methyl-3H-imidazo [4,5-b] pyridin-2-yl, which is useful as a preventive or therapeutic agent for schizophrenia and the like. )] Oxy] phenyl} -1,3-dihydro-2H-imidazo [4,5-b] pyridin-2-one, the powder X-ray diffraction lattice spacing (d) of 13.59 ± It is characterized by having a powder X-ray diffraction pattern in which characteristic peaks appear at 0.2 and 6.76 ± 0.2 angstroms. [Selection figure] None |
priorityDate | 2011-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 585.